Fenton Aron W
Department of Biochemistry and Molecular Biology, The University of Kansas Medical Center, MS 3030, 3901 Rainbow Boulevard, Kansas City, KS, 66160.
Biopolymers. 2013 Nov;100(6):553-7. doi: 10.1002/bip.22239.
Although the classical view of how proteins function relied on well folded structures, it is now recognized that the functions of many proteins are dependent on being intrinsically disordered. The primary consideration in this work is the intermediate group of proteins that are overall well folded, but which contain small regions that undergo order-disorder transitions. In particular, the current focus is on those order-disorder transitions that are energetically coupled to ligand binding. As exemplified by the case of human liver pyruvate kinase (hL-PYK), peptides that mimic the sequence of the order-disorder region can be used as allosteric regulators of the enzyme. On the basis of this example and others reported in the literature, we propose that a similar use of peptides that mimic protein regions that experience ligand-dependent order-disorder transitions can be a generalized initiation point for the development of allosteric drugs.
虽然关于蛋白质如何发挥功能的经典观点依赖于结构良好的折叠状态,但现在人们认识到,许多蛋白质的功能取决于其内在无序性。这项工作的主要关注点是中间类型的蛋白质,它们整体折叠良好,但包含经历有序-无序转变的小区域。特别地,当前的重点是那些在能量上与配体结合相耦合的有序-无序转变。以人肝丙酮酸激酶(hL-PYK)为例,模拟有序-无序区域序列的肽可作为该酶的变构调节剂。基于这个例子以及文献中报道的其他例子,我们提出,类似地使用模拟经历配体依赖性有序-无序转变的蛋白质区域的肽,可以作为开发变构药物的一个通用起始点。